| Literature DB >> 31377556 |
Kristin K Lottman1, Timothy J Gawne2, Nina V Kraguljac3, Jeffrey F Killen4, Meredith A Reid5, Adrienne C Lahti6.
Abstract
Schizophrenia is often characterized by dysconnections in the brain, which can be estimated via functional connectivity analyses. Commonly measured using resting-state functional magnetic resonance imaging (fMRI) in order to characterize the intrinsic or baseline function of the brain, fMRI functional connectivity has significantly contributed to the understanding of schizophrenia. However, these measures may not capture the full extent of functional connectivity abnormalities in schizophrenia as fMRI is temporally limited by the hemodynamic response. In order to extend fMRI functional connectivity findings, the complementary modality of magnetoencephalography (MEG) can be utilized to capture electrophysiological functional connectivity abnormalities in schizophrenia that are not obtainable with fMRI. Therefore, we implemented a multimodal functional connectivity analysis using resting-state 7 Tesla fMRI and MEG data in a sample of first-episode patients with schizophrenia (n = 19) and healthy controls (n = 24). fMRI and MEG data were decomposed into components reflecting resting state networks using a group spatial independent component analysis. Functional connectivity between resting-state networks was computed and group differences were observed. In fMRI, patients demonstrated hyperconnectivity between subcortical and auditory networks, as well as hypoconnectivity between interhemispheric homotopic sensorimotor network components. In MEG, patients demonstrated hypoconnectivity between sensorimotor and task positive networks in the delta frequency band. Results not only support the dysconnectivity hypothesis of schizophrenia, but also suggest the importance of jointly examining multimodal neuroimaging data as critical disorder-related information may not be detectable in a single modality alone.Entities:
Keywords: First-episode; Functional connectivity; Functional magnetic resonance imaging; Independent component analysis; Magnetoencephalography; Schizophrenia
Mesh:
Year: 2019 PMID: 31377556 PMCID: PMC6677917 DOI: 10.1016/j.nicl.2019.101959
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Supplementary Fig. 1Estimate of the number of independent components. The mean number of independent components for fMRI (left) and MEG (right) was estimated to be 32 and 49 for all subjects, respectively, using minimum description length criteria. For fMRI, the minimum and maximum number of components estimated using the minimum description length criteria was 17 and 55, respectively. For MEG, the minimum and maximum number of components estimated using the minimum description length criteria was 12 and 110, respectively.
Fig. 1Composite fMRI and MEG spatial maps. Composite maps of the 30 fMRI (left column) and 33 MEG (right column) resting-state independent component spatial maps. Components are categorized into auditory, sensorimotor, visual, task positive, default-mode, and subcortical networks. Colors in each map represent a different component and are indicated with the component number. The number of components in each network is indicated behind the network name. Peak activations of individual components can be found in Table S1 (fMRI) and Table S2 (MEG) in Supplementary Material.
Demographics and clinical assessments for MEG and fMRI connectivitya.
| HC ( | SZ ( | t/χ2 | ||
|---|---|---|---|---|
| Age (years) | 24.13 ± 5.02 | 23.52 ± 4.64 | 0.415 | 0.680 |
| Gender (male/female) | 17/7 | 15/6 | 0.002 | 0.965 |
| Parental SES | 3.46 ± 3.32 | 4.25 ± 4.38 | 6.272 | 0.617 |
| Education | 3.08 ± 0.58 | 2.85 ± 0.59 | 1.747 | 0.418 |
| Smoking (packs per day) | 0.01 ± 0.06 | 0.07 ± 0.15 | −1.607 | 0.121 |
| Duration of Illness (months) | – | 18.58 ± 26.68 | – | – |
| BPRS | ||||
| Total score | – | 32.26 ± 9.82 | ||
| Positive symptom subscale | – | 5.05 ± 2.95 | ||
| Negative symptom subscale | – | 5.74 ± 2.21 | ||
| SANS | ||||
| Total composite score | – | 21.56 ± 17.81 | ||
| Global summary score | – | 6.47 ± 4.96 | ||
| SAPS | ||||
| Total composite score | – | 7.12 ± 11.77 | ||
| Global summary score | – | 2.47 ± 3.48 | ||
| RBANS | ||||
| Total index | 93.43 ± 8.66 | 74.35 ± 15.31 | 4.579 | <0.001 |
| Immediate memory | 99.67 ± 12.11 | 79.65 ± 14.81 | 4.587 | <0.001 |
| Visuospatial | 86.24 ± 14.98 | 79.94 ± 17.15 | 1.208 | 0.235 |
| Language | 103.71 ± 10.72 | 82.82 ± 11.17 | 5.862 | <0.001 |
| Attention | 96.14 ± 13.54 | 76.47 ± 20.66 | 3.532 | 0.001 |
| Delayed Memory | 92.05 ± 8.27 | 79.88 ± 19.60 | 2.393 | 0.026 |
Abbreviations: HC, healthy control; SZ, schizophrenia; SES, socioeconomic status; Y, yes; N, no; BPRS, Brief Psychiatric Rating Scale; SANS, Scale for the Assessment of Negative Symptoms; SAPS, Scale for the Assessment of Positive Symptoms; RBANS, Repeated Battery for the Assessment of Neuropsychological Status.
Mean ± SD unless otherwise indicated.
SZ values for SES, education, and smoking (packs per day) calculated with n = 20 due to data missing for one patient.
SES ranks reported from Diagnostic Interview for Genetic Studies scale (1–18); high rank (lower numerical value) corresponds to high socioeconomic status.
Years of education reported from Diagnostic Interview for Genetic Studies scale.
Duration of illness (months) calculated with n = 19 due to missing data for 2 patients.
BPRS reported on 1–7 scale; positive (conceptual disorganization, hallucinatory behavior, and unusual thought content); negative (emotional withdrawal, motor retardation, and blunted affect).
SANS includes five subscales: affective flattening or blunting, alogia, avolition-apathy, anhedonia-asociality, and attention.
SANS average total composite score calculated with data from 16 SZ due to missing data from one SZ.
SAPS includes four subscales: hallucinations, delusions, bizarre behavior, and positive formal thought disorder.
RBANS data missing from 3 HC (n = 21) and 3 SZ (n = 17).
Fig. 2Resting-state fMRI and MEG functional connectivity. Functional connectivity for resting-state fMRI (top) and MEG averaged across frequency bands (bottom). Connectivity for controls (left column), first-episode patients (middle column), and the significant difference between groups (right column) are shown. FDR-corrected significant differences (p < 0.05) are indicated with • and uncorrected significant differences (p < 0.05) are indicated with *.
Fig. 3fMRI connectogram and symptom correlations. (A) fMRI connectogram depicting significant (p < 0.05) connectivity differences between patients and controls. Warm colors represent decreased and cool colors represent increased connectivity in patients. (B) Correlation between significant subcortical-auditory connectivity values and patients BPRS positive scores.
Fig. 4Resting-state delta frequency band MEG functional connectivity. Functional connectivity for resting-state MEG delta band. Connectivity for controls (left column), first-episode patients (middle column), and the significant difference between groups (right column) are shown. FDR-corrected significant differences (p < 0.05) are indicated with • and uncorrected significant differences (p < 0.05) are indicated with *.
Fig. 5MEG delta frequency band connectogram. MEG delta band connectogram depicting significant (p < 0.05) connectivity differences between patients and controls. Warm colors represent decreased and cool colors represent increased connectivity in patients.
Supplementary Fig. 2Resting-state theta frequency band MEG functional connectivity. Functional connectivity for resting-state MEG theta band. Connectivity for controls (left column), first-episode patients (middle column), and the significant difference between groups (right column) are shown. FDR-corrected significant differences (p < 0.05) are indicated with • and uncorrected significant differences (p < 0.05) are indicated with *.
Supplementary Fig. 3Resting-state alpha frequency band MEG functional connectivity. Functional connectivity for resting-state MEG alpha band. Connectivity for controls (left column), first-episode patients (middle column), and the significant difference between groups (right column) are shown. FDR-corrected significant differences (p < 0.05) are indicated with • and uncorrected significant differences (p < 0.05) are indicated with *.
Supplementary Fig. 4Resting-state beta frequency band MEG functional connectivity. Functional connectivity for resting-state MEG beta band. Connectivity for controls (left column), first-episode patients (middle column), and the significant difference between groups (right column) are shown. FDR-corrected significant differences (p < 0.05) are indicated with • and uncorrected significant differences (p < 0.05) are indicated with *.
Supplementary Fig. 5Resting-state gamma frequency band MEG functional connectivity. Functional connectivity for resting-state MEG gamma band. Connectivity for controls (left column), first-episode patients (middle column), and the significant difference between groups (right column) are shown. FDR-corrected significant differences (p < 0.05) are indicated with • and uncorrected significant differences (p < 0.05) are indicated with *.
Supplementary Fig. 6Sensorimotor networks spatial correlations. Spatial correlation (r) between resting-state fMRI and MEG components in the sensorimotor network. Only correlations of r > 0.5 are illustrated.
Supplementary Fig. 7Visual networks spatial correlations. Spatial correlation (r) between resting-state fMRI and MEG components in the sensorimotor network. Only correlations of r > 0.5 are illustrated.
Supplementary Fig. 8Default-mode networks spatial correlations. Spatial correlation (r) between resting-state fMRI and MEG components in the default-mode network. Only correlations of r > 0.5 are illustrated.